BNTC: Koefisien rega marang pendapatan Benitec
Benitec Biopharma Inc. (BNTC) is developing an innovative environment based on gene silencing technologies, monetizing its unique intellectual property. The company's average P/S reflects market valuation dynamics, with the metric fixed at 8841.90. Meanwhile, the production of therapeutic molecules is fully delegated to certified partners, and the operating model relies on the outsourcing of clinical trials to minimize capital expenditures.
Rincian analitis perusahaan Benitec (BNTC)
- rega saiki lan proyeksi nilai saham:
- informasi kapitalisasi pasar:
- rincian nilai buku perusahaan:
- indikator beban kredit lan likuiditas emiten:
Rasio Kabeh Utang marang Dana Pribadi Benitec Biopharma Inc.|BNTC - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Benitec Corp|BNTC - Utang perusahaan|Rasio utang marang aset resik Benitec|BNTC - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Benitec Biopharma|Rasio cepet benitec.com
- data bathi lan kelipatan valuasi:
BNTC - Penghasilan resik|Penghasilan resik sing dikarepake Benitec Biopharma Inc.|BNTC - Pangali P/E|Kapitalisasi marang proyeksi bathi Benitec Biopharma Inc|BNTC - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Benitec|BNTC - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Benitec Biopharma|BNTC - Bathi resik saben saham sajrone 12 wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan benitec.com|BNTC - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Benitec Biopharma Inc.
- data total pendapatan lan volume dodolan:
Analisis fundamental perusahaan:benitec.com, BNTC
For Benitec Biopharma Inc. (BNTC), the efficiency of gene therapy logistics and the resilience of biomedical hubs directly determine the market value of every unit of generated revenue. By analyzing the price-to-sales multiple, an investor compares market capitalization with actual revenue to determine the premium paid for future growth; a decrease in this ratio amid stable sales signals undervalued assets and potential for capital appreciation.
Pesaing Benitec Biopharma Inc.
Rasio rega marang pendapatan TEM (Tempus AI)|Multiplikator P/S QGEN (Qiagen)|Koefisien rega marang pendapatan Ionis Pharmaceuticals, Inc. (IONS)|RGEN - Rasio rega marang pendapatan|Rega marang dodolan Avidity Corp|CRISPR Therapeutics AG (CRSP) - Rasio rega marang pendapatan|Rasio rega marang dodolan WGS (genedx.com)|RARE (Ultragenyx) - Multiplikator P/S|BEAM: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S SRPT|Multiplikator P/S Twist Bioscience Corp (TWST)|Rasio rega marang pendapatan 10x Genomics, Inc. TXG|Rasio kapitalisasi pasar marang pendapatan NTLA|STOK - Rasio rega marang pendapatan|BioLife Solutions Inc (BLFS) - Kapitalisasi marang pendapatan|WVE: Multiplikator P/S|Maze Therapeutics Corp (MAZE) - Multiplikator P/S|Kapitalisasi marang pendapatan SION|PRME: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S TSHA|Koefisien rega marang pendapatan uniQure NV|Rasio rega marang pendapatan MeiraGTx PLC MGTX|RGNX: Rasio kapitalisasi marang pendapatan|Solid Biosciences Inc. - Multiplikator P/S|ocugen.com (OCGN) - Kapitalisasi marang pendapatan|PACB (PacBio) - Kapitalisasi marang pendapatan|DSGN - Koefisien rega marang pendapatan|RCKT (Rocket Pharmaceuticals Inc) - Multiplikator P/S|Rasio rega marang pendapatan FDMT|Rasio rega marang pendapatan Lexeo Therapeutics (LXEO)|korrobio.com - Rasio kapitalisasi marang pendapatan|Editas Medicine - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan SLN (Silence Therapeutics PLC)|ProQR Therapeutics NV - Multiplikator P/S|Codexis, Inc. (CDXS) - Kapitalisasi marang pendapatan|SGMO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan NAUT|Rasio rega marang pendapatan Metagenomi|Rasio kapitalisasi marang pendapatan DTIL (precisionbiosciences.com)|Multiplikator P/S GBIO|Multiplikator P/S Boundless Bio Inc (BOLD)|Multiplikator P/S XCUR (Exicure)|Imunon Inc - Rasio rega marang pendapatan|RXi Pharmaceuticals - Multiplikator P/S|Rega marang dodolan Mustang Bio, Inc.|transcodetherapeutics.com (RNAZ) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan BNGO|APDN (Applied DNA Sciences) - Multiplikator P/S|bluebirdbio.com (BLUE) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan IPA (ImmunoPrecise Antibodies)|Kapitalisasi marang volume dodolan OMGA|Multiplikator P/S OMIC (Singular Genomics Systems Inc)|Regulus (RGLS) - Rega marang dodolan|Syros Pharmaceuticals - Multiplikator P/S|telesisbio.com (TBIO) - Kapitalisasi marang pendapatan|TCON (TRACON Pharmaceuticals, Inc.) - Kapitalisasi marang pendapatan|Unity Biotechnology Inc. - Rasio kapitalisasi pasar marang pendapatan
